Enanta PharmaceuticalsENTA
那斯達克 · USD
7.54
-0.08
(-0.99%)
盤中 08/01 02:52 (UTC+8)
08/01 02:52 (UTC+8)
Enanta PharmaceuticalsENTA
7.54
-0.08
(-0.99%)
財務數據
損益表
- 0.24
- 0.18
- 0.19
- 0.19
- 0.18
- 0.17
- 0.18
- 0.15
- 0.17
- 0.15
- 16.09
- -24.55
- 6.16
- 0.21
- -4.91
- -5.27
- 5.38
- -18.72
- 16.10
- -11.99
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 14,926 | 16,959 | 14,607 | 17,971 | 17,054 | 18,003 | 18,932 | 18,892 | 17,795 | 23,585 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 14,926 | 16,959 | 14,607 | 17,971 | 17,054 | 18,003 | 18,932 | 18,892 | 17,795 | 23,585 |
營業費用 | - | - | - | - | - | 52,889 | 49,962 | 55,605 | 57,246 | 53,598 |
研發費用 | 28,065 | 27,656 | 30,778 | 28,742 | 35,585 | 36,371 | 36,167 | 42,987 | 43,468 | 40,902 |
推銷及管理費用 | 11,388 | 12,846 | 13,683 | 13,414 | 14,235 | 16,518 | 13,795 | 12,618 | 13,778 | 12,696 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -24,527 | -23,543 | -29,854 | -24,185 | -32,766 | -34,886 | -31,030 | -36,713 | -39,451 | -30,013 |
其他收入及費用 | 2,292 | 2,799 | 3,249 | 3,487 | 3,809 | 4,298 | 4,664 | 3,866 | 1,837 | 993 |
利息費用 | 1,714 | 1,962 | 2,581 | 2,355 | 2,563 | 3,441 | 3,151 | 1,997 | - | - |
稅前純益 | -23,949 | -22,706 | -29,186 | -23,053 | -31,520 | -34,029 | -29,517 | -34,844 | -37,614 | -29,020 |
所得稅 | -1,305 | -416 | -363 | -395 | -363 | -622 | -1,410 | 4,221 | 44 | -34 |
稅後純益 | -22,644 | -22,290 | -28,823 | -22,658 | -31,157 | -33,407 | -28,107 | -39,065 | -37,658 | -28,986 |
基本每股稅後盈餘(元) | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | - | -1.86 | -1.79 | -1.39 |
稀釋每股稅後盈餘(元) | -1.06 | -1.05 | -1.36 | -1.06 | -1.48 | -1.58 | -1.33 | -1.86 | -1.80 | -1.39 |
基本平均股數(千股) | 21355.00 | 21238.00 | 21190.00 | 21180.00 | 21167.00 | 21088.00 | - | 21054.00 | 21035.00 | 20816.00 |
稀釋平均股數(千股) | 21355.00 | 21238.00 | 21190.00 | 21180.00 | 21167.00 | 21088.00 | - | 21054.00 | 21035.00 | 20816.00 |
還原基本每股稅後盈餘(元) | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | - | -1.86 | -1.79 | -1.39 |
還原稀釋每股稅後盈餘(元) | -1.06 | -1.05 | -1.36 | -1.06 | -1.48 | -1.58 | -1.33 | -1.86 | -1.80 | -1.39 |
還原基本平均股數(千股) | 21,355 | 21,238 | 21,190 | 21,180 | 21,167 | 21,088 | - | 21,054 | 21,035 | 20,816 |
還原稀釋平均股數(千股) | 21,355 | 21,238 | 21,190 | 21,180 | 21,167 | 21,088 | - | 21,054 | 21,035 | 20,816 |
EBITDA(千元) | -20,216 | -19,223 | -27,328 | -20,339 | -28,311 | -29,672 | -25,761 | -33,643 | -38,080 | -28,848 |